Orthofix International reported $-2.22M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
EDAP TMS EUR -5.01M 586K Sep/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
J&J USD 5.12B 36M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
STAAR Surgical USD -18.31M 27.19M Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Veracyte USD 41.15M 22.01M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025